Paper41365876
Identification and targeting oxidative phosphorylation/glycolysis to overcome anti-CSF-1R therapy resistance in glioblastoma.
Miao C and 8 others. Cell Death Dis, 2025. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Identification and targeting oxidative phosphorylation/glycolysis to overcome anti-CSF-1R therapy resistance in glioblastoma. Papers, record 41365876. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41365876
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Identification and targeting oxidative phosphorylation/glycolysis to overcome anti-CSF-1R therapy resistance in glioblastoma.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glioblastoma | Major topic |
| Drug Resistance, Neoplasm | Major topic |
| Oxidative Phosphorylation | Major topic |
| Brain Neoplasms | Major topic |
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | Major topic |
| Animals | |
| Mice | |
| Humans | |
| Temozolomide | |
| Cell Line, Tumor |
Source PubMed
References61
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34696786 | Differential gene expression-based connectivity mapping identified novel drug candidate and improved Temozolomide efficacy for Glioblastoma. | J Exp Clin Cancer Res | 2021 | https://conductscience.org/library/papers/34696786 | PubMed |
| 2 | 33252849 | Mannose synergizes with chemoradiotherapy to cure cancer via metabolically targeting HIF-1 in a novel triple-negative glioblastoma mouse model. | Clin Transl Med | 2020 | https://conductscience.org/library/papers/33252849 | PubMed |
| 3 | 27104977 | On the Dependency of Cellular Protein Levels on mRNA Abundance. | Cell | 2016 | https://conductscience.org/library/papers/27104977 | PubMed |
| 4 | 34950148 | The Colony Stimulating Factor-1 Receptor (CSF-1R)-Mediated Regulation of Microglia/Macrophages as a Target for Neurological Disorders (Glioma, Stroke). | Front Immunol | 2021 | https://conductscience.org/library/papers/34950148 | PubMed |
| 5 | 31850228 | The Binding of PD-L1 and Akt Facilitates Glioma Cell Invasion Upon Starvation via Akt/Autophagy/F-Actin Signaling. | Front Oncol | 2019 | https://conductscience.org/library/papers/31850228 | PubMed |
| 6 | 23227453 | Complex DNA repair pathways as possible therapeutic targets to overcome temozolomide resistance in glioblastoma. | Front Oncol | 2012 | https://conductscience.org/library/papers/23227453 | PubMed |
| 7 | 37987212 | Gene dosage compensation: Origins, criteria to identify compensated genes, and mechanisms including sensor loops as an emerging systems-level property in cancer. | Cancer Med | 2023 | https://conductscience.org/library/papers/37987212 | PubMed |
| 8 | 34562087 | Glioblastoma genetic drivers dictate the function of tumor-associated macrophages/microglia and responses to CSF1R inhibition. | Neuro Oncol | 2022 | https://conductscience.org/library/papers/34562087 | PubMed |
| 9 | 27068937 | Role of the colony-stimulating factor (CSF)/CSF-1 receptor axis in cancer. | Biochem Soc Trans | 2016 | https://conductscience.org/library/papers/27068937 | PubMed |
| 10 | 38751936 | Next generation sequencing technologies to address aberrant mRNA translation in cancer. | NAR Cancer | 2024 | https://conductscience.org/library/papers/38751936 | PubMed |
| 11 | 39905019 | CDCA7 enhances STAT3 transcriptional activity to regulate aerobic glycolysis and promote pancreatic cancer progression and gemcitabine resistance. | Cell Death Dis | 2025 | https://conductscience.org/library/papers/39905019 | PubMed |
| 12 | 32440095 | Pexidartinib, a Novel Small Molecule CSF-1R Inhibitor in Use for Tenosynovial Giant Cell Tumor: A Systematic Review of Pre-Clinical and Clinical Development. | Drug Des Devel Ther | 2020 | https://conductscience.org/library/papers/32440095 | PubMed |
| 13 | 29416029 | Neuroglobin boosts axon regeneration during ischemic reperfusion via p38 binding and activation depending on oxygen signal. | Cell Death Dis | 2018 | https://conductscience.org/library/papers/29416029 | PubMed |
| 14 | 39744695 | A molecularly distinct cell type in the midbrain regulates intermale aggression behaviors in mice. | Theranostics | 2025 | https://conductscience.org/library/papers/39744695 | PubMed |
| 15 | 24810037 | Cell type-specific mRNA purification by translating ribosome affinity purification (TRAP). | Nat Protoc | 2014 | https://conductscience.org/library/papers/24810037 | PubMed |
| 16 | 36230833 | The GBM Tumor Microenvironment as a Modulator of Therapy Response: ADAM8 Causes Tumor Infiltration of Tams through HB-EGF/EGFR-Mediated CCL2 Expression and Overcomes TMZ Chemosensitization in Glioblastoma. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36230833 | PubMed |
| 17 | 38002561 | Molecular Targeted Therapies in Glioblastoma Multiforme: A Systematic Overview of Global Trends and Findings. | Brain Sci | 2023 | https://conductscience.org/library/papers/38002561 | PubMed |
| 18 | 28514441 | PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity. | Nature | 2017 | https://conductscience.org/library/papers/28514441 | PubMed |
| 19 | 31530089 | Diversity, Mechanisms, and Significance of Macrophage Plasticity. | Annu Rev Pathol | 2020 | https://conductscience.org/library/papers/31530089 | PubMed |
| 20 | 38216766 | Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial. | Nat Cancer | 2024 | https://conductscience.org/library/papers/38216766 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42891212 | Beyond M1 M2: single-cell insights into how glioblastoma reshapes tumour-associated macrophages. | Front Immunol | 2026 | https://conductscience.org/library/papers/42891212 | PubMed |
| 42732341 | Tissue-Resident Macrophage in Inflammation and Cancer. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42732341 | PubMed |
| 42483730 | GSTM3 Knockdown Promotes Liver Fibrosis Reversal by Inhibiting Hepatic Stellate Cell Activation via PPARγ Signaling. | J Clin Transl Hepatol | 2026 | https://conductscience.org/library/papers/42483730 | PubMed |
| 42389513 | Epstein-Barr virus-driven immunosuppression in nasopharyngeal carcinoma: a comprehensive review of viral mechanisms, spatial tumor ecosystems, and precision therapeutics. | Front Immunol | 2026 | https://conductscience.org/library/papers/42389513 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41365876
GET https://conductscience.org/api/papers/v1/41365876/references?page=2